Skip to main content
. 2017 May 3;6(5):e005771. doi: 10.1161/JAHA.117.005771

Table 3.

CMR Results

7 Days Post‐AMI 60 Days Post‐AMI
Vehicle (n=7) ATMSCs (n=7) P Value Vehicle (n=7) ATMSCs (n=7) P Value
LVEDV, mL 133.2±17.0 133.4±22.6 0.986 201.3±37.3 190. 6±37.2 0.600
LVESV, mL 80.3±16.9 74.3±15.9 0.510 126.5±35.8 110.6±30.4 0.387
LVEF, % 40.2±5.2 44.4±3.6 0.110 37.9±6.3 42.7±5.2 0.142
Infarct size (% LV) 30.8±5.5 25.0±5.0 0.061 19.1±4.3 15.4±4.7 0.153
MVO (% infarct) 6.2±7.2 6.0±8.1 0.960
Edema (% LV) 32.1±5.4 26.3±4.9 0.059
Infarct size (% edema) 0.96±0.04 0.95±0.06 1.000
Myocardial perfusion, mL/min per gram
Core infarcted area 52.7±35.0 45.6±22.9 0.658 64.5±16.7 69.8±19.6 0.618
Anterior infarct border 57.4±17.7 87.9±28.7 0.034 43.3±14.7 99.0±22.6 <0.001
Septum infarct border 65.5±26.6 71.9±14.8 0.588 60.6±3.7 76.2±30.1 0.237
Posterior remote wall 214.3±73.3 212.5±76.8 0.965 120.2±3.7 179.3±87.5 0.118

Values are represented as mean±SD. Edema sequences and MVO were only available at the 7‐day CMR study.18 AMI indicates acute myocardial infarction; ATMSCs, adipose tissue‐derived mesenchymal stem cells; CMR, cardiac magnetic resonance imaging; LV, left ventricle; LVEDV, left ventricular end‐diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end‐systolic volume; MVO, microvascular obstruction.